ClinicalTrials.gov
ClinicalTrials.gov Menu

Does Block Play Improve Language Acquisition: A Randomized Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00428376
Recruitment Status : Completed
First Posted : January 30, 2007
Last Update Posted : September 29, 2008
Sponsor:
Collaborator:
Megablocks
Information provided by:
University of Washington

Brief Summary:
This is a randomized controlled trial of distributing blocks to children ages 1.5 -2.5 years of age to see if language acquisition improves.

Condition or disease Intervention/treatment Phase
Healthy Device: Building Blocks Not Applicable

Detailed Description:
Children in age group are randomized to get two sets of blocks or not. Outcomes include language development assessed using the Macarthur Bates CDI 6 months after enrollment.

Study Type : Interventional  (Clinical Trial)
Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Official Title: Clinical Trial of Building Block Distribution in Children
Study Start Date : September 2005
Actual Primary Completion Date : September 2006
Actual Study Completion Date : September 2006



Primary Outcome Measures :
  1. Macarthur Bates Language Inventory

Secondary Outcome Measures :
  1. TV viewing
  2. Block play


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Months to 30 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy children

Exclusion Criteria:

  • developmental delay, non-English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00428376


Sponsors and Collaborators
University of Washington
Megablocks
Investigators
Principal Investigator: Dimitri Christakis, MD MPH University of Washington

Responsible Party: Dmitri Christakis, MD, MPH, University of Washington
ClinicalTrials.gov Identifier: NCT00428376     History of Changes
Other Study ID Numbers: 05-0636-01
First Posted: January 30, 2007    Key Record Dates
Last Update Posted: September 29, 2008
Last Verified: September 2008